section_path: Treatment
section_name: Treatment
paragraph_text: Treatment
  
  No treatment for humans is known as of 2008. Ribavirin, a medication used to treat RSV, showed effectiveness in an animal model.
  
  American pharmaceutical corporation Moderna conducted a clinical trial for a candidate modRNA vaccine against metapneumovirus. As of October 2019, the vaccine candidate had passed through phase I, with reports that the vaccine is well-tolerated at all dose levels at two months, and provokes an immune response which boosts the production of neutralising antibodies.
  
  No treatment for humans is known as of 2008. Ribavirin, a medication used to treat RSV, showed effectiveness in an animal model.
  
  American pharmaceutical corporation Moderna conducted a clinical trial for a candidate modRNA vaccine against metapneumovirus. As of October 2019, the vaccine candidate had passed through phase I, with reports that the vaccine is well-tolerated at all dose levels at two months, and provokes an immune response which boosts the production of neutralising antibodies.